Globus Medical's Q3 2025 earnings crushed estimates, with EPS of $1.18 beating by 47%. The stock surged over 22% as the company also raised its full-year profit guidance.
Amprius Technologies, a leader in next-generation lithium-ion batteries, announced its third quarter 2025 business and financial results and will hold a conference call to discuss them.
Nektar Therapeutics (NKTR) Q3 2025 results beat analyst estimates for both revenue and earnings per share, sending the stock higher in after-hours trading.
Chesapeake Utilities (CPK) Q3 2025 results show a strong revenue beat but an earnings miss. Revenue surged 34.5% above estimates, while EPS fell short.
Battery manufacturer EnerSys (NYSE:ENS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.6% year on year to $951.3 million. Guidance for next quarter’s revenue was better than expected at $940 million at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $2.56 per share was 8.8% above analysts’ consensus estimates.
Puma Biotech's Q3 2025 earnings beat expectations, driven by strong NERLYNX sales. The company raised its full-year revenue guidance and advances its clinical pipeline.
Aerospace and defense company Redwire (NYSE:RDW) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 50.7% year on year to $103.4 million. The company’s full-year revenue guidance of $330 million at the midpoint came in 21.9% below analysts’ estimates. Its GAAP loss of $0.29 per share was 93.3% below analysts’ consensus estimates.
Moving and storage solutions provider U-Haul (NYSE:UHAL) met Wall Streets revenue expectations in Q3 CY2025, with sales up 3.7% year on year to $1.72 billion. Its GAAP profit of $0.49 per share was 24.6% below analysts’ consensus estimates.
Payment technology company Crane NXT (NYSE:CXT) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 10.3% year on year to $445.1 million. Its non-GAAP profit of $1.28 per share was 1.8% above analysts’ consensus estimates.
Eventbrite stock surged after a mixed Q3 2025 report. The company beat EPS estimates with a surprise profit and raised its full-year EBITDA outlook, despite a slight revenue miss.
Sweetgreen (SG) stock fell after missing Q3 revenue and earnings estimates. The salad chain reported declining same-store sales and wider losses, leading to a negative market reaction.
AEye (LIDR) Q3 2025 earnings beat revenue estimates by 40% and narrowed its EPS loss. The lidar firm also announced new customer wins and a fortified balance sheet.
Precision motion systems specialist Allient (NASDAQ:ALNT) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 10.8% year on year to $138.7 million. Its non-GAAP profit of $0.59 per share was 20.4% above analysts’ consensus estimates.
Mortgage investment firm Ellington Financial (NYSE:EFC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 23.6% year on year to $82.76 million. Its non-GAAP profit of $0.53 per share was 20.7% above analysts’ consensus estimates.
MP Materials posted mixed Q3 2025 results, missing revenue estimates but beating on adjusted EPS. The company's strategic pivot away from China sales widened its net loss.
Expensify (EXFY) Q3 2025 earnings: Revenue missed estimates, but the company beat on adjusted EPS. Stock fell on paid member decline despite growth in card and travel segments.
Artivion (AORT) Q3 2025 revenue beat expectations with 18.4% YoY growth, while EPS aligned with estimates. The medical device firm shows strong momentum.
VTEX Q3 2025 earnings beat EPS estimates, but revenue slightly missed forecasts. The company posted strong GMV growth and profitability, while providing cautious Q4 guidance.
